Consegna Pharma
Consegna Pharma Inc. is a specialty pharmaceutical company focused on creating best-in-class long-acting medications through its proprietary Computational Drug Delivery™ technology, ADSR™. This AI-based software significantly reduces the time and cost of formulation development and lowers clinical trial and manufacturing risks. The company reformulates known, safe drugs into long-acting injectable (LAI) medications, enabling therapeutic effects for extended periods from a single administration. Their product pipeline targets therapeutic areas with high non-adherence or specific drug delivery challenges, leveraging the 505(b)(2) FDA regulatory pathway for off-patent medications. Their lead product aims to address opioid overdoses with a sustained-release naloxone formulation to prevent renarcotization.
Consegna Pharma
Consegna Pharma Inc. is a specialty pharmaceutical company focused on creating best-in-class long-acting medications through its proprietary Computational Drug Delivery™ technology, ADSR™. This AI-based software significantly reduces the time and cost of formulation development and lowers clinical trial and manufacturing risks. The company reformulates known, safe drugs into long-acting injectable (LAI) medications, enabling therapeutic effects for extended periods from a single administration. Their product pipeline targets therapeutic areas with high non-adherence or specific drug delivery challenges, leveraging the 505(b)(2) FDA regulatory pathway for off-patent medications. Their lead product aims to address opioid overdoses with a sustained-release naloxone formulation to prevent renarcotization.